Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

IGM Biosciences' Cash And Investments As Of June 30, 2024 Were $256.4M, The Company Expects To End 2024 With A Balance Of Approximately $180M In Cash And Investments And For The Balance To Enable It To Fund Its Operating Expenses Into The Second Quarter Of 2026

Author: Benzinga Newsdesk | August 14, 2024 07:21am

Posted In: IGMS